Nitric oxide-dependent and independent down-regulation of NO-sensitive guanylyl cyclase in neural cells

Toxicology Letters

Volumn 149, Issue 1-3, 2004, Pages 75-83

  Sardón, Teresa ^a   Baltrons, María Antonia ^a   García, Agustina ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Astroglia; Cyclic GMP; Nitric oxide; Soluble guanylyl cyclase

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; CYCLIC GMP; GUANYLATE CYCLASE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE DONOR;

ANIMAL CELL; ASTROCYTE; CELL CULTURE; CONFERENCE PAPER; DOWN REGULATION; EXPOSURE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ASTROCYTES; CENTRAL NERVOUS SYSTEM; DOWN-REGULATION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GUANYLATE CYCLASE; HUMANS; NEURONS; NITRIC OXIDE; RATS;

EID: 1842666715     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2003.12.021     Document Type: Conference Paper

References (63)

1. Agulló L., Baltrons M.A., García A. Calcium-dependent nitric oxide formation in glial cells. Brain Res. 686:1995;160-168.
2. Araque A., Carmignoto G., Haydon P.G. Dynamic signaling between astrocytes and neurons. Annu. Rev. Physiol. 63:2001;795-813.
3. Ariano M.A., Lewicki J.A., Brandwein H.J., Murad F. Immunohistochemical localization of guanylate cyclase within neurons of rat brain. Proc. Natl. Acad. Sci. U.S.A. 79:1982;1316-1320.
4. Baltrons M.A., García A. Nitric oxide-independent down-regulation of soluble guanylyl cyclase by bacterial endotoxin in astroglial cells. J. Neurochem. 73:1999;2149-2157.
5. Baltrons M.A., Pedraza C.E., Heneka M.T., García A. β-Amyloid peptides decrease soluble guanylyl cyclase expression in astroglial cells. Neurobiol. Dis. 10:2002;139-149.
6. Bellamy T.C., Wood J., Goodwin D.A., Garthwaite J. Rapid desensitization of the nitric oxide receptor, soluble guanylyl cyclase, underlies diversity of cellular cGMP responses. Proc. Natl. Acad. Sci. U.S.A. 97:2000;2928-2933.
7. Bonkale W.L., Winblad B., Ravid R., Cowburn R.F. Reduced nitric oxide responsive soluble guanylyl cyclase activity in the superior temporal cortex of patients with Alzheimer's disease. Neurosci. Lett. 187:1995;5-8.
8. Budworth J., Meillerais S., Charles I., Powell K. Tissue distribution of the human soluble guanylate cyclases. Biochem. Biophys. Res. Commun. 263:1999;696-701.
9. Corbalán R., Montoliu C., Miñana M.D., Del Olmo J.A., Serra M.A., Aparisi L., Rodrigo J.M., Felipo V. Altered modulation of soluble guanylate cyclase by nitric oxide in patients with liver disease. Metab. Brain Dis. 17:2002;295-301.
10. Davis J.P., Vo X.T., Sulakhe P.V. Altered responsiveness of guanylyl cyclase to nitric oxide following treatment of cardiomyocytes with S-nitroso-D,L-acetylpenicillamine and sodium nitroprusside. Biochem. Biophys. Res. Commun. 238:1997;351-356.
11. Denninger J.V., Marletta M.A. Guanylate cyclase and the NO/cGMP signaling pathway. Biochim. Biophys. Acta. 1411:1999;334-350.
12. De Vente, J., Steinbusch, H.W.M., 2000. Nitric oxide-cGMP signaling in the rat brain. In: Steinbusch, H.W.M., De Vente, J., Vicent, S.R. (Eds.), Functional Neuroanatomy of the Nitric Oxide System. Handbook of Chemical Neuroanatomy, Vol. 17. Elsevier, Amsterdam, pp. 355-415.
13. Ferrero R., Rodriguez-Pascual F., Miras-Portugal M.T., Torres M. Nitric oxide-sensitive guanylyl cyclase activity inhibition through cyclic GMP-dependent dephosphorylation. J. Neurochem. 75:2000;2029-2039.
14. Filippov G., Bloch D.B., Bloch K.D. Nitric oxide decreases stability of mRNAs encoding soluble guanylate cyclase subunits in rat pulmonary artery smooth muscle cells. J. Clin. Invest. 100:1997;942-948.
15. Furuyama T., Inagaki S., Takagi H. Localizations of α1 and β1 subunits of soluble guanylate cyclase in the rat brain. Mol. Brain Res. 20:1993;335-344.
16. Garbers D.L. The guanylyl cyclase receptors. Methods. 19:1999;477-484.
17. García A., Baltrons M.A. The nitric oxide/cyclic GMP pathway in CNS glial cells. Adv. Mol. Cell Biol. 31:2003;575-594.
18. Garthwaite J., Boulton C.L. Nitric oxide signalling in the central nervous system. Annu. Rev. Physiol. 57:1995;683-706.
19. Gibb B.J., Garthwaite J. Subunits of the nitric oxide receptor, soluble guanylyl cyclase, expressed in rat brain. Eur. J. Neurosci. 13:2001;539-544.
20. Gibb B.J., Wykes V., Garthwaite J. Properties of NO-activated guanylyl cyclases expressed in cells. Br. J. Pharmacol. 139:2003;1032-1040.
21. Gross S.S., Wolin M.S. Nitric oxide: pathophysiological mechanisms. Annu. Rev. Physiol. 57:1995;737-769.
22. Hanafy K.A., Krumenacker J.S., Murad F. NO, nitrotyrosine, and cyclic GMP in signal transduction. Med. Sci. Monit. 7:2001;801-819.
23. Heneka M.T., Feinstein D.L. Expression and function of inducible nitric oxide synthase in neurons. J. Neuroimmunol. 114:2001;8-18.
24. Ibarra C., Nedvetsky P.I., Gerlach M., Riederer P., Schmidt H.H. Regional and age-dependent expression of the nitric oxide receptor, soluble guanylyl cyclase, in the human brain. Brain Res. 907:2001;54-60.
25. Jurado S., Sanchez-Prieto J., Torres M. Differential expression of NO-sensitive guanylyl cyclase subunits during the development of rat cerebellar granule cells: regulation via N-methyl-D-aspartate receptors. J. Cell Sci. 116:2003;3165-3175.
26. Kharitonov V.G., Russwurm M., Magde D., Sharma V.S., Koesling D. Dissociation of nitric oxide from soluble guanylate cyclase. Biochem. Biophys. Res. Commun. 239:1997;284-286.
27. Kim Y.-M., Chung H.-T., Kim S.-S., Han J.-A., Yoo Y.-M., Kim K.-M., Lee G.-H., Yun H.-Y., Green A., Li J., Simmons R.L., Billiar T.R. Nitric oxide protects PC12 cells from serum deprivation-induced apoptosis by cGMP-dependent inhibition of caspase signaling. J. Neurosci. 19:1999;6740-6747.
28. Kloss S., Furneaux H., Mulsch A. Post-transcriptional regulation of soluble guanylyl cyclase expression in rat aorta. J. Biol. Chem. 278:2003;2377-2383.
29. Koglin M., Vehse K., Budaeus L., Scholz H., Behrends S. Nitric oxide activates the β2 subunit of soluble guanylyl cyclase in the absence of a second subunit. J. Biol. Chem. 276:2001;30737-30743.
30. Lipton S.A., Singel D.J., Stamler J.S. Nitric oxide in the central nervous system. Prog. Brain Res. 103:1994;359-364.
31. Liu H., Force T., Bloch K.D. Nerve growth factor decreases soluble guanylate cyclase in rat pheochromocytoma PC12 cells. J. Biol. Chem. 272:1997;6038-6043.
32. Llansola M., Minana M.D., Montoliu C., Saez R., Corbalan R., Manzo L., Felipo V. Prenatal exposure to aluminum reduces expression of neuronal nitric oxide synthase and of soluble guanylate cyclase and impairs glutamatergic neurotransmission in rat cerebellum. J. Neurochem. 73:1999;712-718.
33. Loihl A.K., Murphy S. Expression of NOS-2 in glia associated with CNS pathology. Prog. Brain Res. 118:1998;253-267.
34. Lucas K.A., Pitari G.M., Kazerounian S., Ruiz-Stewart I., Park J., Schulz S., Chepenik K.P., Waldman S.A. Guanylyl cyclases and signaling by cyclic GMP. Pharmacol. Rev. 52:2000;375-414.
35. Matsuoka I., Giuli D., Poyard M., Stengel D., Parma J., Guellaen G., Hanoune J. Localization of adenylyl and guanylyl cyclase in rat brain by in situ hybridization: comparison with calmodulin mRNA distribution. J. Neurosci. 12:1992;3350-3360.
36. Miñana M.D., Corbalan R., Montoliu C., Teng C.M., Felipo V. Chronic hyperammonemia in rats impairs activation of soluble guanylate cyclase in neurons and in lymphocytes: a putative peripheral marker for neurological alterations. Biochem. Biophys. Res. Commun. 257:1999;405-409.
37. Mulsch A., Oelze M., Kloss S., Mollnau H., Topfer A., Smolenski A., Walter U., Stasch J.P., Warnholtz A., Hink U., Meinertz T., Munzel T. Effects of in vivo nitroglycerin treatment on activity and expression of the guanylyl cyclase and cGMP-dependent protein kinase and their downstream target vasodilator-stimulated phosphoprotein in aorta. Circulation. 103:2001;2188-2194.
38. Murthy K.S. Activation of phosphodiesterase 5 and inhibition of guanylate cyclase by cGMP-dependent protein kinase in smooth muscle. Biochem. J. 360:2001;199-208.
39. Nakane M., Ichikawa M., Deguchi T. Light and electron microscopic demonstration of guanylate cyclase in rat brain. Brain Res. 273:1983;9-15.
40. Papapetropoulos A., Marczin N., Mora G., Milici A., Murad F., Catravas J.D. Regulation of vascular smooth muscle soluble guanylate cyclase activity, mRNA, and protein levels by cAMP elevating agents. Hypertension. 26:1995;696-704.
41. Papapetropoulos A., Go C., Murad F., Catravas J.D. Mechanisms of tolerance to sodium nitroprusside in cultured rat aortic smooth muscle cells. Br. J. Pharmacol. 117:1996a;147-155.
42. Papapetropoulos A., Abou-Mohamed G., Marczin N., Murad F., Cadwell W., Catravas J.D. Downregulation of nitrovasodilator-induced cyclic GMP accumulation in cells exposed to endotoxin or interleukin-1β Br. J. Pharmacol. 118:1996b;1359-1366.
43. Parkinson S.J., Jovanovic A., Jovanovic S., Wagner F., Terzic A., Waldman S.A. Regulation of nitric oxide-responsive recombinant soluble guanylyl cyclase by calcium. Biochemistry. 38:1999;6441-6448.
44. Pedraza C.E., Baltrons M.A., Heneka M.T., García A. Interleukin-1β and lipopolysaccharide decrease soluble guanylyl cyclase in brain cells: NO-independent destabilization of protein and NO-dependent decrease of mRNA. J. Neuroimmunol. 144:2003;80-90.
45. Russwurm M., Wittau N., Koesling D. Guanylyl cyclase/PSD-95 interaction: targeting of the nitric oxide-sensitive alpha2/beta1 guanylyl cyclase to synaptic membranes. J. Biol. Chem. 276:2001;44647-44652.
46. Russwurm M., Koesling D. Isoforms of NO-sensitive guanylyl cyclase. Mol. Cell. Biochem. 230:2002;159-164.
47. Schulz E., Tsilimingas N., Rinze R., Reiter B., Wendt M., Oelze M., Woelken-Weckmuller S., Walter U., Reichenspurner H., Meinertz T., Munzel T. Functional and biochemical analysis of endothelial (dys)function and NO/cGMP signaling in human blood vessels with and without nitroglycerin pretreatment. Circulation. 105:2002;1170-1175.
48. Serfass L., Carr H.S., Aschenbrenner L.M., Burstyn J.N. Calcium ion downregulates soluble guanylyl cyclase activity: evidence for a two-metal ion catalytic mechanism. Arch. Biochem. Biophys. 387:2001;47-56.
49. Shimouchi S., Janssen St.P., Bloch D.B., Zapol W.M., Bloch K.D. cAMP regulates soluble guanylate cyclase β1-subunit gene expression in RFL-6 rat fetal lung fibroblasts. Am. J. Physiol. 265:1993;L456-L461.
50. Simic G., Lucassen P.J., Krsnik Z., Kruslin B., Kostovic I., Winblad B., Bogdanovi N. nNOS expression in reactive astrocytes correlates with increased cell death related DNA damage in the hippocampus and entorhinal cortex in Alzheimer's disease. Exp. Neurol. 165:2000;12-26.
51. Takata M., Filippov G., Liu H., Ichinose F., Janssens S., Bloch D.B., Bloch K.D. Cytokines decrease sGC in pulmonary artery smooth muscle cells via NO-dependent and NO-independent mechanisms. Am. J. Physiol. Lung Cell Mol. Physiol. 280:2001;L272-L278.
52. Takuma K., Phuagphong P., Lee E., Mori K., Baba A., Matsuda T. Anti-apoptotic effect of cGMP in cultured astrocytes: inhibition by cGMP-dependent protein kinase of mitochondrial permeable transition pore. J. Biol. Chem. 276:2001;48093-48099.
53. Tanaka J., Markerink-Van Ittersum M., Steinbusch H.W.M., De Vente J. Nitric oxide-mediated cGMP synthesis in oligodendrocytes in the developing rat brain. Glia. 19:1997;286-297.
54. Tsuchida S., Hiraoka M., Sudo M., Kigoshi S., Muramatsu I. Attenuation of sodium nitroprusside responses after prolonged incubation of rat aorta with endotoxin. Am. J. Physiol. 267:1994;H2305-H2310.
55. Ujiie K., Hogarth L., Danziger R., Drewett J.G., Yuen P.S.T., Pang I.H., Star R.A. Homologous and heterologous desensitization of a guanylyl cyclase-linked nitric oxide receptor in cultured rat medullary interstitial cells. J. Pharmacol. Exp. Ther. 270:1994;761-767.
56. Waldman S.A., Murad F. Cyclic GMP synthesis and function. Pharmacol. Rev. 39:1987;163-196.
57. 2+ waves in glia. J. Neurosci. 20:2000;1767-1779.
58. Xiong H., Yamada K., Jourdi H., Kawamura M., Takei N., Han D., Nabeshima T., Nawa H. Regulation of nerve growth factor release by nitric oxide through cyclic GMP pathway in cortical glial cells. Mol. Pharmacol. 56:1999;339-347.
59. Zabel U., Weeger M., La M., Schmidt H.H.W. Human soluble guanylate cyclase: functional expression and revised isoenzyme family. Biochem. J. 335:1998;51-57.
60. Zabel U., Kleinschnitz C., Oh P., Nedvetsky P., Smolenski A., Muller H., Kronich P., Kugler P., Walter U., Schnitzer J.E., Schmidt H.H. Calcium-dependent membrane association sensitizes soluble guanylyl cyclase to nitric oxide. Nat. Cell Biol. 4:2002;307-311.
61. Zhang J., Snyder S.H. Nitric oxide in the nervous system. Annu. Rev. Pharmacol. Toxicol. 35:1995;213-233.
62. Zwiller J., Revel M.O., Basset P. Evidence for phosphorylation of rat brain guanylate cyclase by cyclic AMP-dependent protein kinase. Biochem. Biophys. Res. Commun. 101:1981;1381-1387.
63. Zwiller J., Revel M.O., Malviya A.N. Protein kinase C catalyzes phosphorylation of guanylate cyclase in vitro. J. Biol. Chem. 260:1985;1350-1353.